776 B. Torres et al. / Pathology – Research and Practice 207 (2011) 775–779dantrolene on urinary bladder injury that follows SCI in trauma- 10% phosphate-buffered formalin (pH 7.4) and fragments weretized rats. processed by the routine technique of embedding in parafﬁn. Four-micron sections were stained by hematoxylin–eosin (HE)Materials and methods technique for morphological evaluation under light microscopy. The bladder morphometry was performed to quantify amount of This study was approved and performed in agreement with the inﬂammatory inﬁltrate and hemorrhage in eight ﬁelds per ani-Ethical Principles in Animal Experimentation, adopted by the Ethics mal, using a 121-point graticule (40× objective). The results wereCommittee in Animal Experimentation from Federal University of expressed as percentage of lesion per ﬁeld in each group.Minas Gerais (CETEA/UFMG, protocol no. 059/03). Statistical analysisAnimals and surgical procedure All data collected were analyzed using Prism 5 for Win- Forty-six male Wistar rats aged 12 weeks and weighing dows (GraphPad Software. La Jolla, CA, USA). Data from the320–350 g were used in this study. Rats were kept under a urinary bladders were evaluated for statistical signiﬁcance using12/12 h light-dark cycle for 14 days of acclimation with commer- Kruskal–Wallis test with a post hoc Dunn’s multiple comparison.cial rodent food and water ad libitum. Pre-anesthetic medication These data were presented as mean ± SD of the percentage ofwas performed with tramadol (2 mg/kg, orally) and induction and lesions values. In all analyses, p value ≤ 0.05 was considered sta-maintenance was carried out with isoﬂurane administered by mask tistically signiﬁcant.in a semi-opened system. The animals were positioned in proneposition, prepared for aseptic surgery and received prophylac-tic antibiotic therapy with cephalothin (30 mg/kg, intravenous). ResultsSkin and subcutaneous tissue were incised in the dorsal midlineextending from T6 to L1, the paravertebral muscles dissected and Gross and light microscopy ﬁndingslaminectomy of T13 was performed with the employment of apneumatic drill. After visualization of the spinal cord covered by The animals that underwent laminectomy alone (GII and GV)the intact dura, a compressive model of SCI was performed, as pre- showed neither gross nor histological changes in their urinaryviously described [1,5,36], using a weight of 70 g/cm loading to the bladders, while those subjected to SCI had bladder distensiondorsal surface of the spinal cord. Afterwards, the site was irrigated and hemorrhagic cystitis of varying intensity among the differentwith saline, the muscles approximated, and the reduced dead space groups. Histologically, at 32 h after SCI in GI and GIII, there wereand skin sutured using an unabsorbed suture. During anesthetic multifocal areas of hemorrhage in the muscle layers and laminarecovery, the animals were kept warm in a box heated approxi- propria of the urinary bladder, and mixed inﬂammatory inﬁltratemately to 37 ◦ C. They received tramadol (2 mg/kg, orally), every 8 h with macrophages, lymphocytes and neutrophils was also seen. Atfor three days. Abdominal massage was performed three times a eight days post-SCI, the bladders from GIV showed higher lesionday in all animals to assist with urination and defecation. intensity with inﬂammatory inﬁltrate and hemorrhage in all lay- ers when compared with rats that received dantrolene which hadTreatment inﬂammatory inﬁltrate predominantly consisting of macrophages in the lamina propria. Their morphological bladder features were The therapeutic protocol consisted of 10 mg/kg of dantrolene similar to those of non-traumatized animals (Fig. 1).(Cristália Lab. Itapira, SP, Brazil) diluted in 15 ml of water for injec- The quantiﬁcation of these morphological ﬁndings showed thetion given in single dose, intraperitoneally 1 h after laminectomy. amount of hemorrhage and inﬂammatory inﬁltrate in the urinaryThe control groups received only water for injection as placebo bladder. At 32 h after SCI, the animals that received placebo (GI) hadgiven in single dose, intraperitoneally 1 h after laminectomy. signiﬁcantly more hemorrhage (GI = 19%) than those that received dantrolene (GIII = 8.5%) (p < 0.01). At 32 h, the non-injured animalsExperimental groups showed no hemorrhage (GII = 0%). At eight days, the dantrolene- treated animals showed recovery from the hemorrhagic process The animals were randomly divided into six groups according (GVI = 0.6%) compared to the placebo-treated group (GIV = 15%)to the protocol of treatment and the time of euthanasia. GI (n = 7) (p < 0.001) and appeared not different when compared to the non-underwent laminectomy followed by SCI, treated with placebo and injured animals (GV = 0%) (p > 0.05) (Fig. 2). However, althougheuthanized after 32 h; GII (n = 7) underwent laminectomy alone, there was no signiﬁcant difference in the inﬂammatory inﬁltratetreated with placebo and euthanized after 32 h; GIII (n = 8) under- between the traumatized groups at 32 h (GI = 17.7%; GIII = 12.4%), atwent laminectomy followed by SCI, treated with dantrolene and eight days the inﬂammatory inﬁltrate was smaller in animals whoeuthanized after 32 h; GIV (n = 8) underwent laminectomy followed received dantrolene (GVI = 6%) than in those who received placeboby SCI, treated with placebo and euthanized after eight days; GV (GIV = 16%) (p < 0.05) (Fig. 3).(n = 8) underwent laminectomy alone, treated with placebo andeuthanized after eight days; and GVI (n = 8) underwent laminec- Discussiontomy followed by SCI, treated with dantrolene and euthanized aftereight days. The study and its results were carried out by investiga- The results of the current study show that dantrolene has pro-tors who were blind to the experimental conditions. tective effects on spinal cord contusion-induced urinary bladder injury. The impaired integrity of bladder morphology was amelio-Gross and light microscopy rated by dantrolene treatment. Spinal cord injury produces severe deﬁcits within the urogenital Rats were euthanized with an overdose of thiopental by system. The majority of these deﬁcits are the result of disrup-intraperitoneal injection and necropsied to evaluate the integrity tion of supraspinal input to the spinal cord and reorganization ofof the urinary bladder. The harvests were always performed intraspinal circuitry in response to injury . Micturition is medi-in the area visually more impaired. In animals without macro- ated by neural circuits that are located in the lumbosacral cordscopic lesions, the area was taken at random. They were ﬁxed in . Spinal injury above the lumbosacral level damages descending
B. Torres et al. / Pathology – Research and Practice 207 (2011) 775–779 777Fig. 1. Light microscopy sections of urinary bladder of Wistar rats stained with H&E (A) normal bladder: transitional epithelium (EP), lamina propria (LP) and muscularis(TM). Normal urinary bladder of an animal from GII (non-injured – 32 h) – 115.3×, (B) Normal urinary bladder of an animal from GV (non-injured – eight days) – 58.5×;(C) Multifocal areas of hemorrhage (h) and inﬂammatory inﬁltrate (asterisk) in an animal from GI (placebo – 32 h) – 116.6×, (D) Multifocal areas of hemorrhage (h) andinﬂammatory inﬁltrate (asterisk) in an animal from GIII (dantrolene – 32 h) – 115.6×, (E) Inﬂammatory inﬁltrate (asterisk) and hemorrhage (h) in an animal from GIV (placebo– eight days) – 119.5×, (F) Urinary bladder in an animal from GVI (dantrolene – eight days) – 59.2× – showing recovery from hemorrhage process and less inﬂammatoryinﬁltrate that the placebo group at eight days (GIV).pathways that normally coordinate somatic motor (via puden- is contracting (detrusor-sphincter dyssynergia), which impedesdal nerve) and parasympathetic control (via pelvic nerve) of the voiding, leads to large residual urine volume and bladder over-lower urinary tract, altering primary afferent pathways to the ﬁlling, predisposing to inﬂammation and hemorrhagic interstitiallumbosacral cord and, thus, impairing lower urinary tract function cystitis [2,18,25,28,45]. For all these reasons, patients with SCI[6,25]. are at higher risk for bacterial cystitis, chronic bacterial infec- In animal models of SCI, the urinary bladder can undergo tions within and under the uroepithelial layer, and bladder cancersigniﬁcant structural, physiological and molecular alterations. In [2,18,25].those animals, hematuria associated with a cellular inﬂamma- While there are some treatments for controlling detrusortory response and a breakdown of the uroepithelium lining the hyperreﬂexia, for example, antimuscarinic agents such as bethane-lumen of the bladder often occur as a result of bladder over- chol and neurotoxins such as capsaicin and resiniferatoxin,distention. This breakdown is initiated early after injury and is detrusor-sphincter dyssynergia remains difﬁcult to manage with-characterized by a loss of transepithelial resistance and enhanced out catheterization or surgical interventions .permeability to both water and urea. These alterations result from To achieve therapeutic beneﬁts on spinal cord-injured patients,inefﬁcient voiding because the EUS contracts, while the bladder drugs that affect calcium homeostasis have been employed
778 B. Torres et al. / Pathology – Research and Practice 207 (2011) 775–779 the relaxation of the EUS has been previously reported and, con- sidering that voiding is one of the natural protective mechanisms of the urinary system, it is possible that the action of dantrolene on the sphincter has major roles in this process [17,20,32]. Importantly, our ﬁndings showed signiﬁcant improvement of the damaged urinary bladder tissue in rats with SCI that received dantrolene. It is worth noting that, to rule out the possibility that pressure from the manual expression of urine was the source of hematuria, in this study the sham animals experienced bladder expression as well, as performed by Herrera et al. . Even though we have not performed urodynamic tests, we believe that our macroscopic and histological ﬁndings, suggestive of an amelioration of a possible dyssynergia between bladder andFig. 2. Mean ± SD of the percentages of hemorrhage in urinary bladder of Wis- EUS, may be due to the direct action of the drug against the inﬂam-tar rats. GI (placebo – 32 h); GII (non-injured–32 h); GIII (dantrolene – 32 h); GIV matory process in the bladder wall and/or the direct action of the(placebo – 8 days); GV (non-injured–8 days) and GVI (dantrolene – 8 days) (*p ≤ 0.05; drug on the EUS skeletal muscle relaxation allowing a facilitated**p ≤ 0.01; ***p ≤ 0.001). voiding. Moreover, we can suggest the association of these possi- bilities.experimentally. Dantrolene, a ryanodine receptor antagonist, In summary, we demonstrate here, for the ﬁrst time, thatinhibits Ca2+ efﬂux from the endoplasmic reticulum to the cytosol, systemically injected dantrolene ameliorates the urinary bladderresulting in a documented neuroprotective effect [3,21,30,46]. damage that follows SCI. These ﬁndings suggest that dantrolene Evidence for the neuroprotective effects of dantrolene via an may provide a promising additional therapeutic strategy for theantiapoptotic mechanism has been reported after experimental management of SCI and alleviate its consequences. Future investi-induction of neuronal death [26,31,34,43,44]. On the other hand, gation, such as concerning a long-term evaluation with urodynamicfew studies have been performed to investigate the effects of tests, must be done to elucidate the broad potential of this drug anddantrolene on SCI. Thorell et al.  examined the role of intracel- the exact pathway by which dantrolene promotes those beneﬁts.lular calcium in mediating posttraumatic abnormalities in axonalconduction and demonstrated that dantrolene improved electro- Acknowledgmentsphysiological recovery in an in vitro model of compressive injuryto an isolated spinal cord dorsal column segment. Most recently, We wish to thank Cristalia Lab for the drug donation. The studydantrolene afforded neuroprotection in a model of spinal cord was supported by grants from Foundation for Research Supportischemia/reperfusion injury induced by abdominal aortic occlusion of the State of Minas Gerais (FAPEMIG) and National Council ofin rabbits . Torres et al.  showed that dantrolene decreased Scientiﬁc and Technological Development (CNPq).apoptosis and protected neurons in an in vivo model of compressiveSCI in rats. Thus, dantrolene was a promising option to be tested on the Referencesconsequences of an in vivo traumatic SCI model, as it had not been  A.R. Allen, Surgery of experimental lesion of spinal cord equivalent to crushevaluated in such a situation. It was expected that this drug would injury of fracture dislocation of spinal column. A preliminary report, JAMA 57have a protective effect on the impaired urinary bladder following (1911) 878–880.SCI. It was hypothesized to aid in micturition control, ameliorating  G. Apodaca, S. Kiss, W. Ruiz, S. Meyers, M. Zeidel, L. Birder, Disruption of blad- der epithelium barrier function after spinal cord injury, Am. J. Physiol. Renalthe dyssynergia between detrusor and EUS that develops following Physiol. 284 (2003) F966–F976.SCI , resulting in less morphological alterations.  A. Ayar, H. Kelestimur, The inhibitory effects of dantrolene on action potential- The efﬁcacy of dantrolene in treating inﬂammatory and induced calcium transients in cultured rat dorsal root ganglion neurons, Physiol. Res. 51 (2002) 341–346.anti-nociceptive disorders mediated by cytokines  and by  D.C. Baptiste, M.G. Fehlings, Pharmacological approaches to repair the injuredarachidonic acid metabolites [11,15] has already been demon- spinal cord, J. Neurotrauma 23 (2006) 318–334.strated. It was also proven that its antioxidant properties prevent  S. Barut, Y.A. Unlu, A. Karaoglan, M. Tuncdemir, F.K. Dagistanli, M. Ozturk, A. ¸ Colak, The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on ¸lipid peroxidation and protect cells against the toxic effects of oxy- traumatic spinal cord injury in rats, Surg. Neurol. 64 (2005) 213–220.gen free radicals [9,10,41]. Furthermore, the action of this drug on  M.S. Beattie, M.G. Leedy, J.C. Bresnahan, Evidence for alterations of synaptic inputs to sacral spinal reﬂex circuits after spinal cord transection in the cat, Exp. Neurol. 123 (1993) 35–50.  M.S. Beattie, A.A. Farooqui, J.C. Bresnahan, Review of current evidence for apo- ptosis after spinal cord injury, J. Neurotrauma 17 (2000) 915–925.  A.R. Blight, M.H. Tuszynski, Clinical trials in spinal cord injury, J. Neurotrauma 23 (2006) 586–593.  M.E. Büyükokuroglu, I. Gulcin, M. Oktay, O.I. Kufrevioglu, In vitro antioxidant ¸ properties of dantrolene sodium, Pharmacol. Res. 44 (2001) 491–494.  M.E. Büyükokuroglu, S. Taysi, F. Polat, F. Göcer, Mechanisms of the beneﬁcial ¸ effects of dantrolene sodium on ethanol-induced acute gastric mucosal injury in rats, Pharmacol. Res. 45 (2002) 421–425.  M.E. Büyükokuroglu, Anti-inﬂamatory and antinociceptive properties of dantrolene sodium in rats and mice, Pharmacol. Res. 45 (2002) 455–460.  G. Cherednichenko, C.W. Ward, F. Feng, E. Cabrales, L. Michaelson, M. Samso, J.R. López, P.D. Allen, I.N. Pessah, Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163c is attenuated by dantrolene, Mol. Pharmacol. 73 (2008) 1203–1212.  M.J. Crowe, J.C. Bresnahan, S.L. Shuman, J.N. Masters, M.S. Crowe, Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys, Nat. Med. 3 (1997) 73–76.Fig. 3. Mean ± SD of the percentages of inﬂammatory inﬁltrate in urinary bladder  A.S. Dumont, R.J. Dumont, R.J. Oskouian, Will improved understanding of theof Wistar rats. GI (placebo – 32 h); GII (non-injured–32 h); GIII (dantrolene – 32 h); pathophysiological mechanisms involved in acute spinal cord injury improveGIV (placebo – 8 days); GV (non-injured–8 days) and GVI (dantrolene – 8 days) the potential for therapeutic intervention? Curr. Opin. Neurol. 15 (2002)(*p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001). 713–720.
B. Torres et al. / Pathology – Research and Practice 207 (2011) 775–779 779 I. Gülcin, S. Beydemir, M.E. Büyükokuroglu, In vitro and in vivo effects of dantro- ¸  S. Muehlschlegel, J.R. Sims, Dantrolene: mechanisms of neuroprotection and lene on carbonic anhydrase enzyme activities, Biol. Pharm. Bull. 27 (2004) possible clinical applications in the neurointensive care unit, Neurocrit. Care 613–616. 10 (2009) 103–115. M. Gwak, P. Park, K. Kim, K. Lim, S. Jeong, C. Baek, J. Lee, The effects of dantrolene  E. Pedersen, H. Harving, B. Klemar, Effect of dantrolene sodium on the spastic on hypoxic-ischemic injury in the neonatal rat brain, Anesth. Analg. 106 (2008) external urethral sphincter recorded by sphincterometry, J. Urol. 119 (1978) 227–233. 403–405. R.H. Hackler, B.H. Broecker, F.A. Klein, S.M. Brady, A clinical experience with  V. Pikov, J.R. Wrathall, Coordination of the bladder detrusor and the external dantrolene sodium for external urinary sphincter hypertonicity in spinal cord urethral sphincter in a rat model of spinal cord injury: effect of injury severity, injured patients, J. Urol. 124 (1980) 78–81. J. Neurosci. 21 (2001) 559–569. J.J. Herrera, R.J.L. Haywood-Watson II, R. Grill, Acute and chronic deﬁcits in the  B.O. Popescu, M. Oprica, M. Sajin, C.L. Stanciu, O. Bajenaru, A. Predescu, C. Vid- urinary bladder after spinal contusion injury in the adult rat, J. Neurotrauma ulescu, L.M. Popescu, Dantrolene protects neurons against kainic acid induced 27 (2010) 423–431. apoptosis in vitro and in vivo, J. Cell. Mol. Med. 6 (2002) 555–569. R.S. Hotchkiss, D.F. Osborne, G.D. Lappas, I.E. Karl, Calcium antagonists decrease  S. Salomone, G. Soydan, M.A. Moskowitz, J.R. Sims, Inhibition of cerebral vaso- plasma and tissue concentrations of tumor necrosis factor-alpha, interleukin-1 constriction by dantrolene and nimodipine, Neurocrit. Care 10 (2009) 93–102. beta, and interleukin-1 alpha in a mouse model of endotoxin, Shock 3 (1995)  I. Solaroglu, E. Kaptanoglu, O. Okutan, E. Beskonakli, A. Attar, K. Kilinc, Magne- 337–342. sium sulfate treatment decreases caspase-3 activity after experimental spinal I.M. Khalaf, G. Foley, M.M. Elhilali, The effect of dantrium on the canine urethral cord injury in rats, Surg. Neurol. 64 (2005) 17–21. pressure proﬁle, Invest. Urol. 17 (1979) 188–190.  M. Takeda, I. Araki, T. Mochizuki, H. Nakagomi, H. Kobayashi, N. Sawada, H. S. Kobayashi, M.L. Bannister, J.P. Gangopadhyay, T. Hamada, J. Parness, N. Ike- Zakohji, The forefront for novel therapeutic agents based on the pathophysiol- moto, Dantrolene stabilizes domain interactions within the ryanodine receptor, ogy of voiding dysfunction and pharmacological therapy, J. Pharmacol. Sci. 112 J. Biol. Chem. 280 (2005) 6580–6587. (2010) 121–127. C.U. Kocogullari, M. Emmiler, M. Cemek, O. Sahin, A. Aslan, E. Ayva, L. Tur, M.E.  W.E. Thorell, L.G. Leibrock, S.K. Agrawal, Role of RYRs and IP3 receptors Büyükokuroglu, I. Demirkan, A. Cekirdekci, Can dantrolene protect spinal cord after traumatic injury to spinal cord white matter, J. Neurotrauma 19 (2002) against ischemia/reperfusion injury? An experimental study, Thorac. Cardio- 335–342. vasc. Surg. 56 (2008) 406–411.  S. Thuret, L.D.F. Moon, F.H. Gage, Therapeutic interventions after spinal cord A.V. Krassioukov, J.C. Furlan, M.G. Fehlings, Autonomic dysreﬂexia in acute injury, Nat. Rev. Neurosci. 7 (2006) 628–643. spinal cord injury: an under-recognized clinical entity, J. Neurotrauma 20  B.B.J. Torres, F.M.C. Caldeira, M.G. Gomes, R. Serakides, A.M. Viott, A.C. Bertag- (2003) 707–716. nolli, F.B. Fukushima, K.M. Oliveira, M.V. Gomes, E.G. Melo, Effects of dantrolene T. Krause, M.U. Gerbershagen, M. Fiege, R. Weisshorn, F. Wappler, Dantrolene – on apoptosis and immunohistochemical expression of NeuN in the spinal cord a review of its pharmacology, therapeutic use and new developments, Anaes- after traumatic injury in rats, Int. J. Exp. Pathol. 91 (2010) 530–536. thesia 59 (2004) 364–373.  H. Ucüncü, S. Taysi, B. Aktan, M.E. Buyukokuroglu, M. Elmastas, Effect of dantro- ¸ P.Y. Leung, C.S. Johnson, J.R. Wrathall, Comparison of the effects of complete lene on lipid peroxidation, glutathione and glutathione-dependent enzyme and incomplete spinal cord injury on lower urinary tract function as evaluated activities in experimental otitis media with effusion in guinea pigs, Hum. Exp. in unanesthetized rats, Exp. Neurol. 208 (2007) 80–91. Toxicol. 24 (2005) 567–571. F. Li, T. Hayashi, G. Jin, K. Deguchi, S. Nagotani, I. Nagano, M. Shoji, P.H. Chan,  A. Ward, M.O. Chaffman, E.M. Sorkin, Dantrolene. A review of its pharmaco- K. Abe, The protective effect of dantrolene on ischemic neuronal cell death is dynamic and pharmacokinetic properties and therapeutic use in malignant associated with reduced expression of endoplasmic reticulum stress markers, hyperthermia, the neuroleptic malignant syndrome and an update of its use Brain Res. 1048 (2005) 59–68. in muscle spasticity, Drugs 32 (1986) 130–168. X.Z. Liu, X.M. Xu, R. Hu, C. Du, S.X. Zhang, J.W. McDonald, H.X. Dong, Y.J. Wu,  H. Wei, D.C. Perry, Dantrolene is cytoprotective in two models of neuronal cell G.S. Fan, M.F. Jacquin, C.Y. Hsu, D.W. Choi, Neuronal and glial apoptosis after death, J. Neurochem. 67 (1996) 2390–2398. traumatic spinal cord injury, J. Neurosci. 17 (1997) 5395–5406.  H. Wei, P. Leeds, R.W. Chen, W. Wei, Y. Leng, D.E. Bredesen, D.M. T. Mitsui, H. Kakizaki, H. Tanaka, T. Shibata, I. Matsuoka, T. Koyanagi, Immor- Chuang, Neuronal apoptosis induced by pharmacological concentrations of 3- talized neural stem cells transplanted into the injured spinal cord promote hydroxykynurenine: characterization and protection by dantrolene and Bcl-2 recovery of voiding function in the rat, J. Urol. 170 (2003) 1421–1425. overexpression, J. Neurochem. 75 (2000) 81–90. T. Mitsui, I. Fischer, J.S. Shumsky, M. Murray, Transplants of ﬁbroblasts express-  S. Wognum, C.E. Lagoa, J. Nagatomi, M.S. Sacks, Y. Vodovotz, An exploratory ing BDNF and NT-3 promote recovery of bladder and hindlimb function pathways analysis of temporal changes induced by spinal cord injury in the following spinal contusion injury in rats, Exp. Neurol. 194 (2005) 410–431. rat bladder wall: insights on remodeling and inﬂammation, PLoS One 4 (2009) F. Mori, M. Okada, M. Tomiyama, S. Kaneko, K. Wakabayashi, Effects of 1–9. ryanodine receptor activation on neurotransmitter release and neuronal cell  F. Zhao, P. Li, S.R. Chen, C.F. Louis, B.R. Fruen, Dantrolene inhibition of ryanodine death following kainic acid-induced status epilepticus, Epilepsy Res. 65 (2005) receptor Ca2+ release channels. molecular mechanisms and isoform selectivity, 59–70. J. Biol. Chem. 276 (2001) 13810–13816.